Cancer Genetics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CGIX and buy or sell other stocks, ETFs, and their options commission-free!About CGIX
Vyant Bio, Inc. is a biotechnology company, which engages in drug discovery for complex neurodevelopmental and neurodegenerative disorders. The firm's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning.
CEOAndrew D. C. LaFrence, CPA
CEOAndrew D. C. LaFrence, CPA
Employees—
Employees—
HeadquartersCherry Hill, New Jersey
HeadquartersCherry Hill, New Jersey
Founded1999
Founded1999
Employees—
Employees—
CGIX Key Statistics
Market cap1.23M
Market cap1.23M
Price-Earnings ratio-0.09
Price-Earnings ratio-0.09
Dividend yield—
Dividend yield—
Average volume45.95K
Average volume45.95K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.58
52 Week high$1.58
52 Week low$0.141
52 Week low$0.141
Stock Snapshot
As of today, Cancer Genetics(CGIX) shares are valued at $4.61. The company's market cap stands at 1.23M, with a P/E ratio of -0.09.
During the trading day, Cancer Genetics(CGIX) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 45.95K.
The stock's 52-week range extends from a low of $0.14 to a high of $1.58.
The stock's 52-week range extends from a low of $0.14 to a high of $1.58.